Johnson & Johnson: all 3,718 studies

Page 19 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index StudyActive, not recruitingNCT03963349
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene AberrationsCompletedNCT03955913
• A Registry Study of Participants With Multiple Myeloma in Latin AmericaCompletedNCT03955900
• A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy ParticipantsCompletedNCT03953196Early Phase 1
• A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy ParticipantsCompletedNCT03952507Phase 1
• A Study of Orally Administered Pimodivir in Adult Participants With Renal ImpairmentTerminatedNCT03947814Phase 1
• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU TrialActive, not recruitingNCT03947619Not applicable
• Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young AdultsNo longer availableNCT03945903
• A Study to Evaluate the Effect of Itraconazole on JNJ-56136379 in Healthy Adult ParticipantsCompletedNCT03945539Phase 1
• Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)CompletedNCT03942120
• Post-Market Clinical Follow-Up of STRATAFIX™ Spiral PDS™ PLUSCompletedNCT03937011
• A Safety and Tolerability Study of JNJ-72537634 in Healthy ParticipantsCompletedNCT03931447Phase 1
• A Study of JNJ-63898081 in Participants With Advanced Stage Solid TumorsCompletedNCT03926013Phase 1
• A Study of Itraconazole in the Management of Superficial Fungal Infections in IndiaTerminatedNCT03923010Phase 4
• A Study of JNJ-64530440 in Healthy Japanese Male ParticipantsTerminatedNCT03915886Phase 1
• A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)CompletedNCT03915379Phase 1
• Safety and Efficacy of Miglustat in Chinese NPC PatientsCompletedNCT03910621Phase 4
• A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)CompletedNCT03900598Phase 1
• Assessment of Intracellular Cytokines and Markers in Cells (Phase 3)CompletedNCT03896100
• A Videographic Study to Evaluate the Impact of a Pulsed Firing Technique on Staple Line Interventions in Laparoscopic Sleeve GastrectomyCompletedNCT03896061
• Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440WithdrawnNCT03890341Phase 1
• A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady StateCompletedNCT03882255Phase 1
• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerCompletedNCT03871816
• A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male ParticipantsCompletedNCT03864601Phase 1
• A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant DepressionWithdrawnNCT03852160Phase 3
• Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 InfectionApproved for marketingNCT03847376
• Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)Active, not recruitingNCT03838445Not applicable
• SVC Occlusion in Subjects With Acute Decompensated Heart FailureCompletedNCT03836079Not applicable
• Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A InfectionNo longer availableNCT03834376
• Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)Approved for marketingNCT03829579
• Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment OptionsApproved for marketingNCT03825484
• A Study of Orally Administered Pimodivir in Adult Participants With Hepatic ImpairmentCompletedNCT03816631Phase 1
• A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).TerminatedNCT03809650Phase 3
• A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthlyCompletedNCT03809325
• A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy ParticipantsCompletedNCT03808259Phase 1
• A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy ParticipantsCompletedNCT03802682Phase 1
• A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult ParticipantsCompletedNCT03800550Phase 1
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) TherapyCompletedNCT03796858Phase 3
• Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer PatientsCompletedNCT03796052Not applicable
• A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep ApneaCompletedNCT03796026Phase 1
• A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF) Vaccine in AdultsCompletedNCT03795441Phase 1
• Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics ProfilingCompletedNCT03795402
• Cetirizine Chewable Bioequivalence and Food Effect StudyCompletedNCT03772158Phase 1
• A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory AgentCompletedNCT03768960Phase 4
• A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsCompletedNCT03768609Phase 1
• A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyActive, not recruitingNCT03767244Phase 3
• A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and NewbornCompletedNCT03755128
• Golimumab for Adherence in Rheumatoid ArthritisCompletedNCT03729349
• A Study to Evaluate the Safety and Tolerability of JNJ-67670187 in Healthy ParticipantsCompletedNCT03723746Phase 1
• A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World SettingCompletedNCT03720561
• A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare FacilitiesCompletedNCT03713658Phase 4
• NEUWAVE Flexible Probe Study #2WithdrawnNCT03713099Not applicable
• A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult VolunteersCompletedNCT03697889Phase 1
• A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult ParticipantsCompletedNCT03696459Phase 1
• A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupancy of JNJ-64140284 With Newly Developed Transmembrane AMPA Receptor Regulatory Protein (TARP)-Gamma 8 Positron Emission Tomography (PET) [18F]JNJ-64511070 in Healthy MenTerminatedNCT03693391Phase 1
• A Study of JNJ-63733657 in Healthy Japanese ParticipantsCompletedNCT03689153Phase 1
• CERENOVUS Neurothrombectomy Devices RegistryCompletedNCT03685578
• A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy ParticipantsCompletedNCT03682380Phase 1
• Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With ItchCompletedNCT03673059Not applicable
• A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in PortugalCompletedNCT03666715
• A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy ParticipantsCompletedNCT03649997Phase 1
• A Study of Guselkumab in Participants With Familial Adenomatous PolyposisCompletedNCT03649971Phase 1
• Evaluating Accommodative Responses of Soft Contact Lenses for Myopia ControlCompletedNCT03635528Not applicable
• A Study for Schizophrenia Relapse PredictionCompletedNCT03629951
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian ParticipantsTerminatedNCT03618160Phase 1
• Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional DyspepsiaCompletedNCT03617016Phase 4
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Female ParticipantsCompletedNCT03607513Phase 1
• Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory DiseasesCompletedNCT03606499
• A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)CompletedNCT03606057Phase 1
• A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical SettingCompletedNCT03604224
• A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy ParticipantsCompletedNCT03593954Phase 1
• Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)CompletedNCT03587376Early Phase 1
• A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of ErdafitinibTerminatedNCT03587363Phase 1
• A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple DoseCompletedNCT03586843Phase 1
• AAVCAGsCD59 for the Treatment of Wet AMDCompletedNCT03585556Phase 1
• A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy ParticipantsCompletedNCT03581916Phase 1
• VITROS Immunodiagnostic Products hs Troponin IStatus unknownNCT03581578
• An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide FumarateCompletedNCT03577470
• A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)CompletedNCT03574532
• A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDSCompletedNCT03573310Phase 1
• Sustainable Early Episode Clinic Study (SEEC)CompletedNCT03571685Not applicable
• A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization ScheduleCompletedNCT03566940Phase 2
• A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male ParticipantsCompletedNCT03564379Phase 1
• A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTerminatedNCT03563742Phase 3
• Tu Salud (Your Health) Randomized Control Study in Patients With Diabetes Using a Mobile App.Status unknownNCT03556605Not applicable
• A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate CancerCompletedNCT03551782Phase 1
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy ParticipantsCompletedNCT03550950Phase 1
• VITROS Immunodiagnostic Products NT-proBNP IICompletedNCT03548909
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid CancersCompletedNCT03547037Phase 1
• A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl EstradiolCompletedNCT03547024Phase 1
• A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal FunctionCompletedNCT03546205Phase 1
• China ATTUNE® StudyCompletedNCT03542045
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese ParticipantsCompletedNCT03536325Phase 1
• Fluoroquinolone Associated DisabilityCompletedNCT03535558
• A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT03523442Phase 1
• An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate CancerNo longer availableNCT03523338
• Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder CancerTerminatedNCT03518320Phase 1
• Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human MetapneumovirusWithdrawnNCT03502694Phase 2
• A Study of Participants With Advanced Prostate Cancer in CanadaCompletedNCT03501173
• Reducing Lung CongestIon Symptoms in Advanced Heart FailureActive, not recruitingNCT03499236Not applicable

← Johnson & Johnson overview and focus areas